Content equals the label
Purity (%) and content (the actual amount delivered) are not the same thing. We document both, so the amount on the label is the amount you receive — no quiet shortfalls.
B2B Documentation Support
Use this page to align sourcing files, quotation scope, packaging, and buyer-side review before comparing supplier options.
BPC-157 10mg + TB-500 10mg Co-Formulated Vial
Co-formulated vial containing BPC-157 10mg and TB-500 10mg, for qualified B2B sourcing, with per-component batch documentation and a stated TB-500 specification type.
Co-formulated vialBPC-157 10mgTB-500 10mgPer-component COAResearch use only
Review specifications, files, and next-step support before requesting samples.
- Confirm the peptide name, CAS, and core specifications
- Check typical applications and document availability
- Use one inquiry path for pricing, files, samples, or project discussion
Key Review Snapshot
Key Review Snapshot
Start with the review points that shape quotation quality.These checkpoints help buyers align file scope, vial format, packaging, MOQ, lead time, and buyer-side review before comparing supplier offers.
Product FormatCo-formulated lyophilized peptide vial, two components
Supply FocusQualified B2B sourcing of blended vials, with component-level documentation
DocumentationBatch COA stating RP-HPLC and MS results, plus SDS/MSDS and specification sheet. Karl Fischer water content and counter-ion data are arranged per project where a specification requires them.
Quotation ScopeFill amount, vial count, packaging format, MOQ, and lead time are confirmed together at quotation stage.
PackagingSealed lyophilized vial with stopper and cap. Neutral-label or private-label discussion for qualified projects. Store unopened vials sealed and protected from light and moisture, at 2–8 °C as standard or −20 °C for long-term storage. Shelf life is confirmed for the specific product, packaging configuration, and batch documentation rather than stated here as a general figure.
ComplianceLaboratory research use only; buyer-side market, import, labeling, and downstream compliance review required.
Why buyers trust WUMO
Real content, documented — not guesswork
In this market, “99% pure” is often quoted while the amount actually delivered is far less. We keep purity and real content separate, and put both on paper — so BPC-157 10mg + TB-500 10mg Co-Formulated Vial is backed by documents you can check.
Research peptide line — typical purity >99.3–99.4%, every batch MS-checked before release.
Every batch is verified
Identity and quality are confirmed by batch documentation — COA, plus HPLC / MS where applicable — before material is released.
Documented and traceable
Ingredient identity (INCI / CAS), specification sheet and SDS are available for review. Match the documents to your quoted batch before you commit.
Documents Available
Documents Available
COA
Batch-specific COA
Batch-level quality summary for buyer-side file review.
Request this file through the inquiry path below.
HPLC
HPLC purity report
Purity profile reference for the quoted project or batch where available.
Request this file through the inquiry path below.
MS
MS identity report
Identity confirmation support for documentation review where available.
Request this file through the inquiry path below.
SDS
SDS / MSDS
Safety document requested for internal purchasing and handling review.
Request this file through the inquiry path below.
Spec
Product specification sheet
Product or packaging specification reference for quotation alignment.
Request this file through the inquiry path below.
Overview
Overview
B2B Review Guide
B2B Review Guide
Product Overview
This is a co-formulated lyophilized vial containing two peptides: BPC-157 at 10mg and TB-500 at 10mg. It is supplied for qualified B2B research sourcing projects. This page describes sourcing and analytical documentation only; it does not describe biological action, combination rationale, end-user application, or product performance.
“TB-500” needs to be pinned down in writing
The name “TB-500” is used inconsistently across the commercial peptide market. In the analytical literature it generally refers to an N-acetylated thymosin β4 fragment, whereas some commercial catalogues apply the same name to full-length thymosin β4. Those are chemically different materials with different molecular weights and different costs.
The specification supplied here is a fragment, not full-length thymosin β4. That is stated openly because it is the most common place for a buyer to be surprised after delivery. Confirm the exact sequence or molecular specification in writing before ordering, and check it against the molecular weight shown on the identity record — the spectrum will tell you which material you have. If a supplier will not state which one they are quoting, that answer is itself informative.
What to check on a blended vial
- Component-level documentation. The analytical record should distinguish BPC-157 from TB-500 and state how identity and purity were assessed for each. Where a component-specific RP-HPLC purity figure is given, the method needs adequate chromatographic separation to support it.
- The ratio is part of the specification. 10mg + 10mg and 10mg + 5mg are different products, and the ratio belongs in the written specification and on the label.
- Total weight is not total peptide. Counterion content, residual moisture, and any excipient sit inside the vial weight — confirm what the per-vial claim is measured against.
What WUMO Can Supply
- Co-formulated vials at the 10mg + 10mg specification as standard
- Alternative ratios and fill quantities by project
- Batch-specific COA distinguishing the two components
- Neutral-label or private-label packaging, with components and ratio stated on the label
- Single-component vials as an alternative — see BPC-157 vial supply and TB-500 vial supply
- MOQ, lead time, and phased delivery planning
Quality and Documentation
A batch-specific COA is issued for the batch being supplied and states the RP-HPLC and mass-spectrometry results for that batch. Purity and peptide content are separate specifications — see what a 10mg vial actually contains for the distinction and what a per-vial claim needs behind it.
Karl Fischer water content, counter-ion form, and appearance are not part of the standard vial COA scope and are arranged per project where a buyer specification requires them. Ask for the COA of the batch being quoted, and check that the batch identifier on it matches the vial label.
Compliance Note
This page is for qualified B2B technical evaluation and business-side documentation review only. Material is supplied for research and laboratory use. It is not intended for individual purchase, consumer use, or product-use guidance, and WUMO does not provide medical guidance or outcome claims. Final use, importation, labeling, and local compliance are the buyer's responsibility.
Frequently Asked Questions
Which TB-500 is in this vial?
A fragment specification, not full-length thymosin β4. Because the trade name is applied inconsistently, confirm the exact sequence in writing and check it against the molecular weight on the identity record.
Should a blended vial have one COA or two sets of results?
One COA is fine, but it should distinguish the components and say how identity and purity were assessed for each. A single combined purity figure does not adequately describe either component.
Can the ratio be changed?
Yes, alternative ratios and fill quantities are set per project, and whatever is agreed should appear in the written specification and on the vial label.
What should I send to get a quotation?
Company and business type, destination market, intended business use, required documentation package, target ratio and fill quantity, vial count, packaging preference, and required timeline.
Specification and documentation references
- Lyophilized vial sourcing guide — fill amount, packaging, MOQ and documentation.
- What a 10mg vial actually contains — peptide content, counterion, moisture and excipients.
- How peptide identity is confirmed by mass spectrometry — what an identity record can and cannot establish.
OEM / Private Label
Want BPC-157 10mg + TB-500 10mg Co-Formulated Vial under your own brand?
For finished lyophilized peptide vials with custom labels and packaging -- covering MOQ, sample or pilot evaluation, and batch documentation such as COA, sterility, and endotoxin reports -- see our private label peptide vial (OEM / ODM) service.
Request Pricing, Files, or Samples
Use this form for pricing, technical files, sample requests, or project discussion for this product.
Need COA, SDS/MSDS, or specifications? Choose "Technical document request" in the inquiry form or mention the file name in your message.